UNSPSC 51143201: Disulfiram

This classification denotes a multidrug resistance modulator and angiogenesis inhibitor with the molecular formula C10H20N2S4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TR3MLJ1UAI, chemically known as 1,1-dithiobis(n,n-diethylthioformamide) but generally known as disulfiram, which bears US NIH Compound Identifier 3117. European Medicines Agency schedules Disulfiram in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06326MIG. The term DISULFIRAM is an International Non-Proprietary Name.

UNSPSC 51143201 Disulfiram is a Commodity code that nominally covers a specific pharmaceutical product used in alcohol-use-disorder treatment, but the recent state and local procurement activity tagged under this code does not reflect that scope. Seminole County, Florida issued an IFB in mid-2023 for naloxone and drug deactivation systems — opioid-overdose reversal and pharmaceutical waste management — neither of which aligns with disulfiram's therapeutic use or chemical classification. The mismatch suggests either a tagging error in the source data or a jurisdictional classification practice that does not map cleanly to the UNSPSC nominal definition. State and local procurement under this code shows minimal recent activity, and the single posted opportunity is misaligned with the code's stated scope.

No additional state and local opportunities under UNSPSC 51143201 appear in the source. The Seminole County solicitation (IFB60459723LAS, posted June 30, 2026, due July 26, 2023) is the only recent record, and it does not represent actual disulfiram procurement activity. Geographic or issuing-body patterns cannot be inferred from a single misaligned opportunity. Firms evaluating this code should verify the actual pharmaceutical or medical-supply categories their target jurisdictions use for substance-abuse treatment and overdose-reversal programs, as the UNSPSC indexing in this instance does not appear to reflect the work being bought.